Thomas J. Errico Buys 6,000 Shares of electroCore, Inc. (NASDAQ:ECOR) Stock

electroCore, Inc. (NASDAQ:ECOR) Director Thomas J. Errico purchased 6,000 shares of the company’s stock in a transaction on Monday, March 17th. The stock was acquired at an average price of $8.10 per share, with a total value of $48,600.00. Following the completion of the purchase, the director now directly owns 256,401 shares in the company, valued at $2,076,848.10. This trade represents a 2.40 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

electroCore Stock Performance

NASDAQ ECOR opened at $8.38 on Wednesday. The company has a market capitalization of $55.78 million, a P/E ratio of -4.58 and a beta of 0.24. electroCore, Inc. has a one year low of $5.32 and a one year high of $19.49. The stock has a 50 day moving average price of $15.47 and a 200-day moving average price of $12.38.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Geode Capital Management LLC boosted its position in shares of electroCore by 10.3% during the 3rd quarter. Geode Capital Management LLC now owns 63,485 shares of the company’s stock valued at $458,000 after acquiring an additional 5,951 shares during the last quarter. HighTower Advisors LLC purchased a new stake in electroCore in the third quarter worth $255,000. Jane Street Group LLC purchased a new stake in electroCore in the fourth quarter worth $278,000. JPMorgan Chase & Co. increased its stake in electroCore by 31,250.0% in the fourth quarter. JPMorgan Chase & Co. now owns 3,762 shares of the company’s stock worth $61,000 after purchasing an additional 3,750 shares during the period. Finally, Marshall Wace LLP purchased a new stake in electroCore in the fourth quarter worth $438,000. 26.74% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. HC Wainwright restated a “buy” rating and issued a $25.00 price target on shares of electroCore in a research note on Thursday, March 13th. LADENBURG THALM/SH SH dropped their price target on electroCore from $28.00 to $26.00 and set a “buy” rating for the company in a research note on Thursday, March 13th.

About electroCore

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.